A coalition of major pharmacy organizations urged Congressional leaders to enact long-stalled PBM reforms to curb ...

Recent changes to ACIP leadership and vaccine guidance have raised concerns that longstanding immunization protections are ...

The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups ...

Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical ...

An Eli Lilly drug candidate designed to hit three metabolic targets led patients to lose an average of 28.7% of their body weight in a late-stage clinical trial, setting a new high mark in the ...

Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a pivotal ...

Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can ...

In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come. All healthcare entities ...

Senate Finance Committee Chairman Mike Crapo (R-Idaho) and Ranking Member Ron Wyden (D-Oregon) introduced a bill Thursday that aims to bring more transparency into the practices of pharmacy benefit ...

The deadline for extending the Affordable Care Act subsidies is approaching this month. This is happening even as consumers who depend on the ACA Marketplace are faced with the tough decision. Should ...

One of the hotter areas of cancer drug research involves using a particular type of bispecific antibody as the backbone for therapeutic combinations intended to bring a multi-pronged attack to tumors.